Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study

Jehan Dupuis, Emmanuel Bachy, Franck Morschhauser, Guillaume Cartron,Noriko Fukuhara,Nicolas Daguindau,René-Olivier Casasnovas,Sylvia Snauwaert,Remy Gressin, Christopher P Fox, Francesco Annibale d’Amore,Philipp B Staber,Olivier Tournilhac,Krimo Bouabdallah, Catherine Thieblemont,Marc André,Shinya Rai,Daisuke Ennishi, Argyrios Gkasiamis, Mitsufumi Nishio,Luc-Matthieu Fornecker,Marie-Helene Delfau-Larue,Nouhoum Sako,Sebastien Mule,Laurence de Leval,Philippe Gaulard,Kunihiro Tsukasaki, François Lemonnier

The Lancet Haematology(2024)

Cited 0|Views13
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined